Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-19

Clinical Trial Update: Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose [NA]

View source ↗

Summary

A completed Tufts University clinical trial examined how dietary changes influence the hepatic lipase LIPC -514 C/T variant and its associations with lipid leve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tufts University | Conditions: Dyslipidemia, Impaired Glucose Tolerance | NA | Status: COMPLETED